IL90743A - Method of producing attenuated polio virus and compound containing it - Google Patents
Method of producing attenuated polio virus and compound containing itInfo
- Publication number
- IL90743A IL90743A IL9074389A IL9074389A IL90743A IL 90743 A IL90743 A IL 90743A IL 9074389 A IL9074389 A IL 9074389A IL 9074389 A IL9074389 A IL 9074389A IL 90743 A IL90743 A IL 90743A
- Authority
- IL
- Israel
- Prior art keywords
- poliovirus
- cdna
- rna
- viral
- sequences
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36361189A | 1989-06-08 | 1989-06-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL90743A0 IL90743A0 (en) | 1990-01-18 |
IL90743A true IL90743A (en) | 1996-01-19 |
Family
ID=23430924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9074389A IL90743A (en) | 1989-06-08 | 1989-06-25 | Method of producing attenuated polio virus and compound containing it |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0401421B1 (ja) |
JP (1) | JPH0310683A (ja) |
AT (1) | ATE132527T1 (ja) |
AU (1) | AU630099B2 (ja) |
DE (1) | DE68925356T2 (ja) |
DK (1) | DK340489A (ja) |
ES (1) | ES2084587T3 (ja) |
FI (1) | FI893346A (ja) |
GR (1) | GR3018670T3 (ja) |
IL (1) | IL90743A (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004003045A1 (de) | 2004-01-20 | 2005-08-18 | Man Roland Druckmaschinen Ag | Formatanpassung für Produktionsdaten |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8800100D0 (en) * | 1988-01-05 | 1988-02-10 | Almond J W | Attenuated viruses |
EP0325768B1 (en) * | 1988-01-11 | 1995-04-26 | American Cyanamid Company | Non-reverting rna viruses |
GB8901094D0 (en) * | 1989-01-18 | 1989-03-15 | Almond Jeffrey W | Attenuated viruses |
-
1989
- 1989-06-21 EP EP89111281A patent/EP0401421B1/en not_active Expired - Lifetime
- 1989-06-21 ES ES89111281T patent/ES2084587T3/es not_active Expired - Lifetime
- 1989-06-21 AT AT89111281T patent/ATE132527T1/de not_active IP Right Cessation
- 1989-06-21 DE DE68925356T patent/DE68925356T2/de not_active Expired - Fee Related
- 1989-06-25 IL IL9074389A patent/IL90743A/en not_active IP Right Cessation
- 1989-06-28 AU AU37134/89A patent/AU630099B2/en not_active Ceased
- 1989-07-07 JP JP1174353A patent/JPH0310683A/ja active Pending
- 1989-07-10 DK DK340489A patent/DK340489A/da not_active Application Discontinuation
- 1989-07-10 FI FI893346A patent/FI893346A/fi not_active Application Discontinuation
-
1996
- 1996-01-16 GR GR950402391T patent/GR3018670T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE68925356T2 (de) | 1996-09-05 |
FI893346A0 (fi) | 1989-07-10 |
EP0401421B1 (en) | 1996-01-03 |
DE68925356D1 (de) | 1996-02-15 |
FI893346A (fi) | 1990-12-09 |
JPH0310683A (ja) | 1991-01-18 |
AU630099B2 (en) | 1992-10-22 |
IL90743A0 (en) | 1990-01-18 |
AU3713489A (en) | 1990-12-13 |
EP0401421A3 (en) | 1991-01-30 |
ATE132527T1 (de) | 1996-01-15 |
ES2084587T3 (es) | 1996-05-16 |
GR3018670T3 (en) | 1996-04-30 |
DK340489A (da) | 1990-12-09 |
EP0401421A2 (en) | 1990-12-12 |
DK340489D0 (da) | 1989-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Andino et al. | Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′‐end of viral RNA. | |
Venuti et al. | Isolation and molecular cloning of a fast-growing strain of human hepatitis A virus from its double-stranded replicative form | |
EP0076847B1 (en) | Cdna representing rna viral sequences | |
RU2723353C1 (ru) | Термочувствительные аттенуированные штаммы вируса ящура (fmdv), способ их конструирования и применение | |
Moss et al. | Mapping of attenuating sequences of an avirulent poliovirus type 2 strain | |
CN113564131B (zh) | 柯萨奇病毒a6型毒株及其应用 | |
KR0178399B1 (ko) | 장을 통해 전염되는 비a비b형 간염 바이러스 병원체 및 그것의 특유한 에피토프 | |
CN113564130B (zh) | 柯萨奇病毒a10型毒株及其应用 | |
EP0325768B1 (en) | Non-reverting rna viruses | |
CN103328004A (zh) | 感染性戊型肝炎病毒基因型3的重组体 | |
Locher et al. | Rapid detection and characterization of foot-and-mouth disease virus by restriction enzyme and nucleotide sequence analysis of PCR products | |
Cameron-Wilson et al. | Nucleotide sequence of an attenuated mutant of coxsackievirus B3 compared with the cardiovirulent wildtype: assessment of candidate mutations by analysis of a revertant to cardiovirulence | |
EP0496875B1 (en) | METHODS FOR PRODUCING RNA VIRUSES FROM cDNA | |
CN107298700B (zh) | 人工改造的PCV2 Rep蛋白、重组PCV2病毒及其应用 | |
Meyer et al. | Genetic variation of foot-and-mouth disease virus from field outbreaks to laboratory isolation | |
Spieker | A new sequence variant of Coleus blumei viroid 1 from the Coleus blumei cultivar ‘Rainbow Gold’ | |
CN113564132B (zh) | 柯萨奇病毒a16型毒株及其应用 | |
EP0401421B1 (en) | Non-reverting RNA viruses | |
Wood et al. | Laboratory tests for live attenuated poliovirus vaccines | |
McCarthy et al. | Molecular characterisation of Australian bovine enteroviruses | |
Spicker et al. | A new sequence variant of coleus blumei viroid 3 from the coleus blumei cultivar ‘Fairway Ruby’ | |
Kanno et al. | Viruses produced from complementary DNA of virulent and avirulent strains of swine vesicular disease viruses retain the in vivo and in vitro characteristics of the parental strain | |
Hema et al. | Construction of an infectious cDNA clone of foot-and-mouth disease virus type O 1 BFS 1860 and its use in the preparation of candidate vaccine | |
Rezapkin et al. | Reevaluation of nucleotide sequences of wild-type and attenuated polioviruses of type 3 | |
Mahravani et al. | GENETIC AND ANTIGENIC ANALYSIS OF TYPE 0 AND A FMD VIRUSES ISOLATED IN IRAN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
RH | Patent void |